Feb. 12, 2007 | Illumina has introduced a flexible, high-throughput DNA methylation profiling technology capable of surveying up to 1,536 methylation sites across 96 samples simultaneously. Using Illumina’s BeadArray platform with the GoldenGate assay approach, researchers can perform genome-wide methylation profiling across multiple areas, such as cancer. The GoldenGate Methylation Cancer Panel I covers 1,505 methylation sites over 800 cancer genes. According to the company, reproducibility rates are greater than 0.98 and custom-content methylation panels will soon be available.
Product: GoldenGate Methylation Profiling Technology
For more information: www.illumina.com